More cases of skin cancer are diagnosed each year than of breast, prostate, lung, and colon cancers combined, and early detection is critical.
A new blood test assesses levels of circulating tumor DNA (ctDNA) in patients with unresectable stage IIIC/IV melanoma.
Clinicians should communicate thoroughly with patients to ensure their injuries will heal properly based on their lifestyle.
A non-invasive laser test can accurately identify melanoma with 100% accuracy.
Many moles increases melanoma risk, but fewer moles are linked to more aggressive forms of melanoma.
Clinicians should warn patients about the dangers of sunburn and discourage this new trend.
Men who took erectile dysfunction medication had increased risk for melanoma, but it is probably due to lifestyle factors.
Methylsulfonylmethane may help treat osteoarthritis and may eventually create a way to detect melanoma.
People who drank one to three cups a day had about a 10% decreased risk of melanoma compared with those who drank none at all.
The prevalence of itch was 36.9%, and the prevalence of pain was 28.2% across all skin cancer, but these symptoms were mainly absent in melanomas
Avoiding unnecessary sun exposure and routine melanoma screenings help protect patients with HIV/AIDS.
Brush up on the basics of preventing, recognizing and addressing melanoma among your patient ranks.
Mekinist plus tafinlar is newly approved for people with late-stage melanoma who have certain mutations in the BRAF V600E and V600K genes.
Doctors discourage getting tattoos over pre-existing lesions after discovering a cancerous mole on a patient during tattoo removal.
Surveillance on the part of primary-care clinicians is critical to the timely identification of cancerous lesions in at-risk individuals.
Adding several additional criteria such as amelanosis, bleeding and color uniformity, among others, may aid in better melanoma detection.
Has any research been conducted to determine whether the incidence of various types of skin cancer is greater in people who fly for a living compared with the general public?
The incidence of pediatric melanoma has increased by about 2% per year since 1973.
One-in-four melanoma survivors report they do not wear sunscreen when going outside on a warm sunny day.
Men typically seek treatment after melanoma has already progressed to later stages, accounting for higher mortally rates compared with women.
Melanoma risk increases with each additional session of sunbed use per year, and for those whose first use was before age 35 years.
Patients may already know they should use a SPF 30 sunscreen, but are they applying it properly?
Teen girls will come up with 100 reasons to use tanning beds. We as health-care providers need to give parents one really big reason to say no.
More young adults, particularly women, are being diagnosed with cutaneous melanoma, but overall and disease-specific survival is improving.
Highest risk seen for patients with previous diagnosis of cutaneous melanoma
MelaFind, a computer-assisted melanoma-detecting device developed by MELA Sciences, has received FDA pre-market approval (PMA) for use on atypical cutaneous pigmented lesions.
When discussing indoor tanning with adolescent patients, appealing to their sense of vanity can go a long way toward dissuading them from engaging in risky behaviors.